Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy

摘要

The present invention provides the use of 8-Prenylflavanones of the general formula I: wherein R1  designates a hydrogen atom, a hydroxyl group in position 2', 3' or 4', a methoxy group in position 2', 3' or 4' or an ethoxy group in position 3' or 4', R2  designates a hydrogen atom, a hydroxyl group in position 3', 4', 5' or 6', a methoxy group in position 3' or 4' or an ethoxy group in position 5', R3  designates a hydrogen atom, a hydroxyl group in position 4', 5' or 6' or a methoxy group in position 4', 5' or 6', R4  designates a hydrogen atom or a hydroxyl group, for the preparation of a pharmaceutical composition for the treatment or prevention of angiogenesis-related diseases and for the treatment or prevention of thrombotic disorders.